Jul 13, 2026 08:00AM
May 11, 2026 04:05PM
Apr 13, 2026 04:05PM
Apr 13, 2026 04:05PM
Mar 4, 2026 06:44AM
Mar 3, 2026 04:05PM
Nov 19, 2025 10:06AM The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care
Nov 6, 2025 04:05PM
Aug 11, 2025 04:05PM
Aug 6, 2025 07:00AM
Aug 4, 2025 11:35AM
Aug 4, 2025 11:35AM
Dec 2, 2024 09:01AM
Dec 2, 2024 09:00AM Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus
Nov 5, 2024 06:43AM
Aug 26, 2024 04:05PM
Aug 26, 2024 04:05PM
Jan 5, 2024 09:00AM
Jan 5, 2024 09:00AM
Nov 9, 2023 04:13PM
Nov 9, 2023 04:05PM Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-directed Allogeneic CAR T Therapy, for Patients with Lupus Nephritis, Extraren
Aug 3, 2023 04:05PM
May 8, 2023 04:05PM
Apr 10, 2023 04:08PM
Apr 10, 2023 04:05PM
Apr 10, 2023 04:05PM
Jan 26, 2023 04:05PM
Jan 26, 2023 04:05PM Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-targeted Allogeneic CAR T Therapy for Patients with B-Cell Malignancies
Jan 26, 2023 04:05PM
Jul 11, 2022 06:30AM
Jun 5, 2022 08:00PM
Jun 2, 2022 07:58AM
Jun 2, 2022 07:00AM
Feb 28, 2022 09:00AM
Jan 10, 2022 04:31PM Sana Biotechnology (SANA), IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct
Jan 10, 2022 04:30PM
Jan 10, 2022 04:30PM
Jan 10, 2022 04:30PM
Jan 10, 2022 04:30PM
Dec 7, 2021 06:00AM
Jun 14, 2021 07:52PM

325,893 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All